The role of lymphadenectomy in endometrial cancer

Clinical Obstetrics and Gynecology

Volumn 54, Issue 2, 2011, Pages 235-244

  Kehoe, Siobhan M ^a   Miller, David S ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Endometrial cancer; lymph node dissection; lymphadenectomy; staging

Indexed keywords

CA 125 ANTIGEN; TECHNETIUM 99M;

ARTICLE; BLEEDING; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CURETTAGE; CYSTIC LYMPHANGIOMA; DEEP VEIN THROMBOSIS; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FROZEN SECTION; HUMAN; HYSTERECTOMY; LAPAROSCOPIC SURGERY; LAPAROTOMY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHEDEMA; LYMPHOSCINTIGRAPHY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; PEROPERATIVE CARE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROGNOSIS; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; ROBOTICS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; THERAPY EFFECT; TUMOR VOLUME; ULTRASOUND;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PELVIS;

EID: 79955567748     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e318218577b     Document Type: Article

References (25)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60:277-300.
2. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60: 2035-2041.
3. Soliman PT, FrumovitzM, Spannuth W, et al. Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol. 2010;119:219-294.
4. Chi DS, BarakatRR, Palayekar MJ, et al. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer. 2008;18:269-273. (Pubitemid 351365228)
5. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol. 2004;92:744-751. (Pubitemid 38251372)
6. Leitao MM, Kehoe S, Barakat RR, et al. Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol. 2008;111:244-248.
7. Kucera E, Kainz C, Reinthaller A, et al. Accuracy of intraoperative frozen-section diagnosis in stage I endometrial adenocarcinoma. Gynecol Obstet Invest. 2000;49:62-66. (Pubitemid 30032425)
8. Kayikcioglu F, Borna N, Meydanli MM, et al. Is frozen-section diagnosis a reliable guide in surgical treatment of stage I endometrial carcinoma? Acta Oncol. 2002;41:444-446. (Pubitemid 35222043)
9. Mariani A, Dowdy SC, Cliby WA, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008;109:11-18.
10. Hricak H, Rubinstein LV, Gherman GM, et al. MR imaging evaluation of endometrial carcinoma: results of NCI cooperative study. Radiology. 1991;179: 829-832.
11. Todo Y, Okamoto K, Hayashi M, et al.A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial cancer for tailoring the indication of lymphadenectomy. Gynecol Oncol. 2007;104: 623-628. (Pubitemid 46240251)
12. Frumovitz M, Slomovitz BM, Singh DK, et al. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg. 2004;199:388-393. (Pubitemid 39120053)
13. May K, Bryant A, O'Dickinson H, et al. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. 2010;20:CD007585.
14. Kitchener H, Swart AM, Qian Q, et al; ASTEC Study Group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet. 2009;373: 125-136.
15. Blake P, Swart AM, Orton J, et al; STEC/ En.5 Study Group. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG En.5 randomized trials): pooled trial results, systematic review, and metastatic-analysis. Lancet. 2009; 373:137-146.
16. Cragun JM, Havrilesky LJ, Calingaert B, et al. Retrospective analysis of selective lymphadenectomy in apparent earlystage endometrial cancer. J Clin Oncol. 2005;23:3668-3675.
17. Kilgore LC, Partridge EE, Alvarez RD, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 1995;56: 29-33.
18. Todo Y, Hidenori K, Masanori K, et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375:1165-1172.
19. Chan JK, Cheung MK, Huh WK, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer. 2006;107: 1823-1830. (Pubitemid 44582951)
20. Lutman CV, Havrilesky LJ, Cragun JM, et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol. 2006; 102:92-97. (Pubitemid 43870232)
21. Abu-Rustum NR, Iasonos A, Zhou Q, et al. Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? Am J Obstet Gynecol. 2008;198:457. e1-457.e5.
22. Abu-Rustum NR, Gomez JD, Alektiar KM, et al. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecol Oncol. 2009;115:236-238.
23. TodoY,YamamotoR,Minobe S, et al.Risk factors for postoperative lower-extremity lymphedemain endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol. 2010;119:60-64.
24. Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, et al. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol. 2009; 113:163-169.
25. Cohn DE, Huh WK, Fowler JM, et al. Cost effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma. Obstet Gynecol. 2007;109:1388-1395. (Pubitemid 46869879)